v3.25.4
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Schedule Of Share Based Compensation Restricted Stock Units The following table includes the number of RSUs granted, vested, forfeited and outstanding to certain employees of the Adviser, officers of the Company and non-employee Board members under the 2018 LTIP and 2023 LTIP:

Grant Date

 

Shares Granted

 

 

Shares Vested

 

 

Shares Forfeited

 

 

Shares Outstanding

 

December 10, 2019

 

 

73,701

 

 

 

73,701

 

 

 

 

 

 

 

May 11, 2020

 

 

179,858

 

 

 

173,750

 

 

 

6,108

 

 

 

 

February 15, 2021

 

 

191,506

 

 

 

185,099

 

 

 

6,407

 

 

 

 

February 17, 2022

 

 

185,111

 

 

 

74,621

 

 

 

5,301

 

 

 

105,189

 

April 11, 2023

 

 

186,770

 

 

 

52,761

 

 

 

4,644

 

 

 

129,365

 

April 3, 2024

 

 

191,937

 

 

 

31,780

 

 

 

2,998

 

 

 

157,159

 

April 4, 2025

 

 

229,371

 

 

 

 

 

 

 

 

 

229,371

 

 Total

 

 

1,238,254

 

 

 

591,712

 

 

 

25,458

 

 

 

621,084

 

Schedule of Number of RSUs Outstanding

As of December 31, 2025, the number of RSUs granted, vested, forfeited and outstanding was as follows (dollars in thousands):

 

Dates

 

Number of RSUs

 

 

Value (1)

 

Outstanding December 31, 2023

 

 

569,732

 

 

$

27,467

 

Granted

 

 

191,937

 

 

 

11,315

 

Vested

 

 

(93,353

)

(2)

 

(4,464

)

Forfeited

 

 

(4,786

)

 

 

(247

)

Outstanding December 31, 2024

 

 

663,530

 

 

$

34,071

 

Granted

 

 

229,371

 

 

 

12,510

 

Vested

 

 

(268,446

)

(2)

 

(10,972

)

Forfeited

 

 

(3,371

)

 

 

(197

)

Outstanding December 31, 2025

 

 

621,084

 

 

$

35,412

 

 

(1)
Value is based on the number of RSUs granted multiplied by the most recent NAV per share on the date of grant, which was $54.54 for the April 4, 2025 grant, $58.95 for the April 3, 2024 grant, $63.04 for the April 11, 2023 grant, $54.14 for the February 17, 2022 grant, $36.56 for the February 15, 2021 grant and $30.82 for the May 11, 2020 grant. Related to the accelerated RSU award vestings, the NAV per share on the date of modification was $54.56.
(2)
Certain grantees elected to net the taxes owed upon vesting against the shares of Common Stock issued resulting in 191,340 shares of Common Stock being issued for the year ended December 31, 2025, and 73,520 shares of Common Stock being issued for the year ended December 31, 2024, as shown on the consolidated statements of stockholders' equity.
Schedule of Outstanding RSUs

The vesting schedule for the outstanding RSUs is as follows:

 

Vest Date

 

RSUs Vesting (1)

 

February 17, 2026

 

 

105,189

 

April 3, 2026

 

 

22,451

 

April 4, 2026

 

 

67,252

 

April 11, 2026

 

 

21,561

 

April 3, 2027

 

 

22,451

 

April 4, 2027

 

 

54,040

 

April 11, 2027

 

 

107,804

 

April 3, 2028

 

 

112,256

 

April 4, 2028

 

 

54,040

 

April 4, 2029

 

 

54,040

 

 

 

 

621,084

 

 

(1)
As of December 31, 2025, upon the successful completion of a Company Listing Event or change of control of the Company, 260,200 RSUs would vest immediately, instead of vesting on the final time vesting date according to the schedule above.
Schedule of Nonvested Performance-Based Units Activity

As of December 31, 2025, the number of performance shares earned was as follows (dollars in thousands):

 

Dates

 

Number of performance shares

 

 

Value (1)

 

Outstanding December 31, 2024

 

 

23,794

 

 

$

1,433

 

Earned

 

 

31,726

 

 

 

1,911

 

Vested

 

 

(55,520

)

(2)

 

(3,344

)

Forfeited

 

 

 

 

 

 

Outstanding December 31, 2025

 

 

 

 

$

 

 

(1)
Value is based on the number of performance shares granted multiplied by the most recent NAV per share on the date the share is granted, which was $60.23 for the shares earned during the year ended December 31, 2023 and shares deemed to be earned on June 10, 2025.
(2)
Certain grantees elected to net the taxes owed upon vesting against the shares of Common Stock issued resulting in 26,721 shares of Common Stock being issued for the year ended December 31, 2025, as shown on the consolidated statements of stockholders’ equity.